These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 17620083)

  • 1. Importance of 5-hydroxytryptamine receptors on intestinal afferents in the regulation of visceral sensitivity.
    Greenwood-van Meerveld B
    Neurogastroenterol Motil; 2007 Aug; 19 Suppl 2():13-8. PubMed ID: 17620083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility.
    Gershon MD
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():3-14. PubMed ID: 15521849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological, pathophysiological and therapeutic impact of the enteric serotonergic system.
    Molderings GJ
    Arzneimittelforschung; 2012 Apr; 62(4):157-66. PubMed ID: 22438071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of serotonin in the pathophysiology of the irritable bowel syndrome].
    Moskwa A; Boznańska P
    Wiad Lek; 2007; 60(7-8):371-6. PubMed ID: 18175558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT system in the gut: roles in the regulation of visceral sensitivity and motor functions.
    Grundy D
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():63-7. PubMed ID: 18924445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and role of 5-HT7 receptor in brain and intestine in rats with irritable bowel syndrome.
    Zou BC; Dong L; Wang Y; Wang SH; Cao MB
    Chin Med J (Engl); 2007 Dec; 120(23):2069-74. PubMed ID: 18167178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients.
    Kerckhoffs AP; Ter Linde JJ; Akkermans LM; Samsom M
    Neurogastroenterol Motil; 2008 Aug; 20(8):900-7. PubMed ID: 18363639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease.
    Spiller R
    Neurogastroenterol Motil; 2007 Aug; 19 Suppl 2():25-31. PubMed ID: 17620085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenteric afferent sensitivity to cholecystokinin and 5-hydroxytryptamine.
    Grundy D; Hillsley K; Kirkup AJ; Richards W
    Dtsch Tierarztl Wochenschr; 1998 Dec; 105(12):466-8. PubMed ID: 9932018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enterochromaffin cells and 5-HT signaling in the pathophysiology of disorders of gastrointestinal function.
    Crowell MD; Shetzline MA; Moses PL; Mawe GM; Talley NJ
    Curr Opin Investig Drugs; 2004 Jan; 5(1):55-60. PubMed ID: 14983974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome.
    Stasi C; Bellini M; Bassotti G; Blandizzi C; Milani S
    Tech Coloproctol; 2014 Jul; 18(7):613-21. PubMed ID: 24425100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of serotonin in gastrointestinal physiology and pathology.
    Cirillo C; Vanden Berghe P; Tack J
    Minerva Endocrinol; 2011 Dec; 36(4):311-24. PubMed ID: 22322654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroanatomy of extrinsic afferents supplying the gastrointestinal tract.
    Berthoud HR; Blackshaw LA; Brookes SJ; Grundy D
    Neurogastroenterol Motil; 2004 Apr; 16 Suppl 1():28-33. PubMed ID: 15066001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel.
    Gershon MD
    Aliment Pharmacol Ther; 1999 May; 13 Suppl 2():15-30. PubMed ID: 10429737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suspended moxibustion relieves chronic visceral hyperalgesia via serotonin pathway in the colon.
    Zhou EH; Liu HR; Wu HG; Shi Y; Wang XM; Tan LY; Yao LQ; Zhong YS; Jiang Y; Zhang LL
    Neurosci Lett; 2009 Feb; 451(2):144-7. PubMed ID: 19114087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated electro-acupuncture attenuates chronic visceral hypersensitivity and spinal cord NMDA receptor phosphorylation in a rat irritable bowel syndrome model.
    Tian SL; Wang XY; Ding GH
    Life Sci; 2008 Aug; 83(9-10):356-63. PubMed ID: 18694764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of serotonin in the pathophysiology of irritable bowel syndrome.
    Crowell MD
    Am J Manag Care; 2001 Jul; 7(8 Suppl):S252-60. PubMed ID: 11474910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatments targeting putative mechanisms in irritable bowel syndrome.
    Cremonini F; Talley NJ
    Nat Clin Pract Gastroenterol Hepatol; 2005 Feb; 2(2):82-8. PubMed ID: 16265125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enteric descending and afferent neural signaling stimulated by giant migrating contractions: essential contributing factors to visceral pain.
    Sarna SK
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G572-81. PubMed ID: 16990445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tachykinin receptor antagonists in irritable bowel syndrome.
    Lecci A; Valenti C; Maggi CA
    Curr Opin Investig Drugs; 2002 Apr; 3(4):589-601. PubMed ID: 12090730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.